• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Transbound Emerg Dis . PA-X Protein Assists H9N2 Subtype Avian Influenza Virus in Escaping Immune Response of Mucosal Dendritic Cells

tetano

Editor, Senior Moderator
Transbound Emerg Dis


. 2022 Jul 20.
doi: 10.1111/tbed.14665. Online ahead of print.
PA-X Protein Assists H9N2 Subtype Avian Influenza Virus in Escaping Immune Response of Mucosal Dendritic Cells


Tao Qin[SUP] 1 2 3 4 [/SUP], Yulian Chen[SUP] 1 [/SUP], Dandan Huangfu[SUP] 1 [/SUP], Yinyan Yin[SUP] 5 [/SUP], Xinyu Miao[SUP] 1 [/SUP], Yuncong Yin[SUP] 1 2 3 4 [/SUP], Sujuan Chen[SUP] 1 2 3 4 [/SUP], Daxin Peng[SUP] 1 2 3 4 [/SUP], Xiufan Liu[SUP] 1 2 3 [/SUP]



Affiliations

Abstract

H9N2 subtype low pathogenicity avian influenza virus (AIV) poses a potential zoonotic risk. PA-X, a novel protein generated by PA gene ribosomal frameshift, is considered to be the virulence factor of H9N2 subtype AIVs. Our study found that rTX possessing PA-X protein enhanced the mammalian pathogenicity of H9N2 subtype AIVs compared with PA-X-deficient virus (rTX-FS). Furthermore, PA-X protein inhibited H9N2 subtype AIVs to infect dendritic cells (DCs), but not nonimmune cells (MDCK cells). Meanwhile, PA-X protein suppressed the phenotypic expression (CD80, CD86, CD40, and MHCII), early activation markers (CD69), and pro-inflammatory cytokines (IL-6 and TNF-α), whereas increased anti-inflammatory cytokine (IL-10) in DCs. After intranasally viral infection in mice, we found that PA-X protein of H9N2 subtype AIVs reduced CD11b[SUP]+[/SUP] and CD103[SUP]+[/SUP] subtype mucosal DCs recruitment to the nasal submucosa by inhibiting CCL20 expression. Moreover, PA-X protein abolished the migratory ability of CD11b[SUP]+[/SUP] and CD103[SUP]+[/SUP] DCs into draining cervical lymph nodes (CLNs) by downregulating CCR7 expression. The rTX-infected DCs significantly impaired the allogeneic CD4[SUP]+[/SUP] T cell proliferation, suggesting PA-X protein suppressed the immune functions of DCs for hindering the downstream immune activation. These findings indicated that PA-X protein assisted H9N2 subtype AIVs in escaping immune response of mucosal DCs for enhancing the pathogenicity. This article is protected by copyright. All rights reserved.

Keywords: Avian influenza virus; Dendritic cells; H9N2; Innate immunity; PA-X protein; Pathogenicity.
 
Back
Top Bottom